Skip to main content
. 2021 Jan 26;23:1136–1160. doi: 10.1016/j.omtn.2021.01.024

Figure 1.

Figure 1

Overview of risk factors, pathogenesis, epigenetic regulation, and currently available targeted inhibitors associated with restenosis

Targeted inhibitors are shown may address pathophysiological pathways associated with the formation and development of restenosis following stenting in coronary artery disease.